Skip to main content
All lobbying filings

THE PETRIZZO GROUP, INC.

Lobbying for OMEROS CORPORATION · Pharmaceuticals

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 15, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
Washington

Official filing document

 Government bodies contacted 3
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Medical/Disease Research/Clinical Labs

Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House. FDA Rare Disease Center of Excellence

Health Issues

Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House. FDA Rare Disease Center of Excellence

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem